Pulmatrix, Inc. (“Pulmatrix,” the “Company,” “we,” “our” or “us”) (NASDAQ: PULM) today announced the termination of its previously planned underwritten public offering, with Oppenheimer & Co., Inc. as sole bookrunner, pursuant to a Registration Statement on Form S-1, File No. 333-229092.
February 6, 2019
· 3 min read